世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

幹細胞技術と応用市場レポート:2023-2033


Stem Cell Technologies and Applications Market Report 2023-2033

レポート詳細 幹細胞技術と応用市場レポート 2023-2033 : 本レポートは、業界とその基礎となる原動力をより深く理解したい場合、新たな収益ポケットを目指す大手企業にとって貴重なものとなるでしょ... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 図表数 言語
Visiongain
ヴィジョンゲイン社
2023年11月6日 GBP4,500
部署ライセンス
ライセンス・価格情報・注文方法はこちら
337 317 英語

※上記価格は部署ライセンス(Departmental licence)価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

レポート詳細

幹細胞技術と応用市場レポート 2023-2033: 本レポートは、業界とその基礎となる原動力をより深く理解したい場合、新たな収益ポケットを目指す大手企業にとって貴重なものとなるでしょう。異業種への進出や既存事業の新地域への展開を目指す企業にも有用です。

政府支援の拡大が市場成長を牽引
幹細胞の研究開発に対する政府支援の拡大は、幹細胞企業の成長を後押ししている。2022年には、この分野で多くの重要な進展が見られた。世界各国政府は幹細胞研究に多額の投資を行っている。例えば、米国国立衛生研究所(NIH)は2022年に37億ドルの資金を幹細胞研究に提供した。幹細胞企業を支援するための新たなプログラムも政府によって導入されつつある。例えば、英国政府は2022年、幹細胞企業が新規治療法を 市場に導入するのを支援するため、3,000万ポンド(3,700万ドル)相 当の新たな基金を設立した。

さらに、この業界には発展途上の傾向がある。これは、この業界に対する投資家の 関心が高まっていることを示している。幹細胞企業のヴァーヴ・セラピューティクスは、2022年の新規株式公開(IPO)で1億ドルを調達した。

以下は、2022年に起こった幹細胞企業の具体的な進歩である:
- 幹細胞治療の臨床研究 2022年、いくつかの幹細胞治療が臨床試験に導入された。例えば、Bluebird Bio社によって、鎌状赤血球症に対する幹細胞治療の第3相臨床試験が開始された。
- 幹細胞企業の規制クリアランス: 2022年、多くの幹細胞企業が規制当局の承認を得た。例えば、幹細胞事業を展開するカイト・ファーマは、非ホジキンリンパ腫の治療に幹細胞を使用することをFDAから承認された。

これらは、2022年に幹細胞分野で見られた数々の進歩のほんの一握りに過ぎない。このような成長は、主に政府からの支援の高まりによるものであり、今後数年間、幹細胞企業の拡大だけでなく、新しい幹細胞医薬品の創出も促進されると期待されている。

幹細胞治療の高コストが業界の成長を妨げる
最先端の医療技術である幹細胞治療によって、様々な病気や障害が改善される可能性がある。しかし、幹細胞治療にかかる費用の高さは、大きな障害となっている。使用される幹細胞の種類、治療される病気、治療センターの場所にもよりますが、今日の幹細胞治療の平均的な費用は5,000ドルから50,000ドルです。

幹細胞治療の価格が高いのは、様々な要因によるものです。幹細胞治療法の開発・製造にかかる価格もその要因の一つである。幹細胞治療の製造は難しく、高度な知識と技術が要求される。また、幹細胞治療は患者ごとにカスタマイズされることが多いため、その費用はさらにかさむ。

保険が適用されないことも、幹細胞治療の価格を引き上げる理由の一つである。現在、幹細胞治療は実験的治療とみなされているため、保険会社の大半は保険適用外となっています。そのため、患者は治療費の全額を負担することになります。

市場調査レポートを購入する前にすべき質問とは?
- 幹細胞技術と応用市場はどのように進化しているのか?
- 幹細胞技術と応用市場を牽引する要因と阻害要因は何か?
- 幹細胞技術と応用の各サブマーケットは予測期間中にどのように成長し、2033年にはどれくらいの売上を占めるようになるのか?
- 2023年から2033年にかけて、幹細胞技術と応用の各サブマーケットの市場シェアはどのように成長するのか?
- 2023年から2033年にかけて、市場全体を牽引する主な要因は何か?
- 幹細胞技術と応用の主要市場はマクロ経済の動きに大 きく追随するのか、それとも各国の市場が他を凌駕するのか。
- 2033年までに各国市場のシェアはどのように変化し、どの地域が2033年の市場をリードするのか。
- また、2033年に市場をリードするのはどの地域なのか?
- これらの大手企業が取り組んでいる幹細胞技術と応用プロジェクトとは?
- 2023年から2033年にかけて、業界はどのような進化を遂げるのか?幹細胞技術と応用プロジェクトは、現在、そして今後10年間でどのような展開を見せるのか?
- 幹細胞技術と応用市場をさらに拡大するために、製品化の必要性は高まっているのか?
- 幹細胞技術と応用の市場はどこに向かっているのか、そしてどのようにすれば市場の最前線に立つことができるのか?
- 新製品や新サービスへの最適な投資方法とは?
- 企業を新たな成長軌道に乗せ、C-suiteへと導くための重要な展望とは?

幹細胞技術と応用市場が、現在、そして今後10年間にどのような影響を受けるのかを知る必要がある:
- 本レポートは337ページにわたり、119の表と198の図表で構成されています。
- 本レポートでは、業界における主要な有望分野にスポットを当てているため、今すぐターゲットを絞ることができます。
- 世界、地域、国の売上と成長に関する詳細な分析が含まれています。
- 競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。

本レポートは、幹細胞技術と応用市場が今後10年間でどのように発展していくのか、またCOVID-19の景気後退と回復の変動に合わせてどのように発展していくのかをお伝えします。この市場は、過去10年間のどの時期よりも今が重要である。

2033年までの予測やその他の分析から、商業的な展望が明らかになる
- 2033年までの収益予測に加え、直近の業績、成長率、市場シェアもご覧いただけます。
- ビジネスの展望と展開に関する独自の分析をご覧いただけます。
- 質的分析(市場ダイナミクス、促進要因、機会、阻害要因、課題など)、コスト構造、幹細胞技術と応用の価格上昇の影響、最近の動向をご覧いただけます。

本レポートには、COVID-19が業界と貴社にどのような影響を与えるかについてのデータ分析と貴重な洞察が含まれている。本レポートでは、COVID-19の4つの回復パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じている。

レポート対象セグメント

タイプの展望
- 同種幹細胞療法
- 自家幹細胞療法

細胞源
- 脂肪組織由来MSCs
- 骨髄由来MSC
- 胎盤・臍帯由来MSC

製品
- 成体幹細胞
- ヒト胚性幹細胞
- 人工多能性幹細胞
- 極小胚様幹細胞

技術
- 細胞取得
- 細胞生産
- 凍結保存
- 拡大・サブカルチャー
- その他の技術

応用分野
- 癌
- 心血管疾患
- 神経疾患
- 炎症性・自己免疫疾患
- 筋骨格系疾患
- その他の用途

エンドユーザー
- 製薬・バイオテクノロジー企業
- 病院・細胞バンク
- 学術・研究機関

世界市場全体と各分野の収益予測に加え、5つの地域と米国、中国、英国、インド、ブラジルの主要国市場の収益予測も掲載している:

北米
- アメリカ
- カナダ

欧州
- ドイツ
- 英国
- フランス
- スペイン
- イタリア
- その他の欧州

アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋地域

ラテンアメリカ
- ブラジル
- メキシコ
- その他のラテンアメリカ

MEA
- GCC
- 南アフリカ
- その他のMEA

また、幹細胞技術と応用市場の2023年から2033年にかけての主要企業のプロファイルと、これらの企業の事業のこのセグメントに焦点を当てたいくつかの企業についても掲載している。

主要企業と市場成長の可能性
・ Athersys, Inc.
・ Becton, Dickinson and Company
・ Biorestorative Therapies, Inc.
・ CELLAÏON SA
・ Cynata Therapeutics Limited
・ Merck KGaA
・ Mesoblast Limited
・ Plus Therapeutics, Inc.
・ Sangamo Therapeutics, Inc.
・ STEMCELL Technologies Inc.
・ Thermo Fisher Scientific Inc.
・ Vericel Corporation

幹細胞技術と応用市場の2023年から2033年にかけての世界全体の売上高は、金額ベースで2023年に100億米ドルを突破する。2033年まで力強い収益成長を予測。当研究所では、最大の可能性を秘めた組織を特定しています。彼らの能力、進歩、商業的展望を発見し、一歩先を行くお手伝いをします。

幹細胞技術と応用市場、2023年から2033年までのレポートはどのように役立つのでしょうか?
要約すると、弊社の330ページを超えるレポートは以下の知識を提供します:

- 幹細胞技術と応用市場の2023年から2033年までの収益予測 世界および地域レベルでのタイプ、細胞源、製品、技術、アプリケーション、最終用途の各予測を掲載 - 業界の将来性を発見し、投資と収益に最も有利な場所を見つけることができます。

- 5つの地域と20の主要国市場の2033年までの収益予測 - 北米、欧州、アジア太平洋、中南米、MEAの幹細胞技術と応用市場の2023年から2033年までの市場予測をご覧ください。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなどの著名経済圏の市場も予測しています。

- 2023年から2033年までの幹細胞技術とアプリケーション市場に関わる主要企業のサーモフィッシャーサイエンティフィック社、ベクトン・ディッキンソン社、STEMCELLテクノロジーズ社、メルクKGaA社の企業プロファイルを含む。

独自の予測による定量的・定性的分析をご覧ください。私たちのレポートだけに含まれる情報を入手し、貴重なビジネスインテリジェンスで情報を得ることができます。

他にはない情報
私たちの新しいレポートがあれば、知識に遅れをとったり、チャンスを逃したりする可能性が低くなります。Visiongainの調査レポートが貴社の調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainのこの調査レポートは、幹細胞技術と応用市場(2023年~2033年)の商業分析を必要とするすべての人、市場をリードする企業を対象としています。データ、トレンド、予測をご覧いただけます。



ページTOPに戻る


目次

目次

1 レポート概要
1.1 研究の目的
1.2 幹細胞技術と応用市場の紹介
1.3 本レポートの内容
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問
1.6 本レポートは誰のためのものか?
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問(FAQ)
1.9 Visiongainの関連レポート
1.10 Visiongainについて

2 エグゼクティブ・サマリー

3 市場概要
3.1 主要な調査結果
3.2 市場ダイナミクス
3.2.1 市場促進要因
3.2.1.1 幹細胞治療に対する意識の高まり
3.2.1.2 幹細胞研究に対する政府の支援
3.2.1.3 臨床試験数の増加
3.2.2 市場抑制要因
3.2.2.1 幹細胞治療の高コスト
3.2.2.2 規制の明確性の欠如
3.2.3 市場機会
3.2.3.1 幹細胞研究開発への投資の増加
3.3 COVID-19インパクト分析
3.4 ポーター分析
3.5 PEST分析

4 幹細胞技術と応用市場分析:タイプ別
4.1 主要な調査結果
4.2 タイプ別セグメント 市場魅力度指数
4.3 幹細胞技術と応用のタイプ別市場規模の推定と予測
4.4 同種幹細胞療法
4.4.1 2023~2033年の地域別市場規模(US$ Million)
4.4.2 地域別市場シェア、2023年・2033年(%)
4.5 自己幹細胞療法
4.5.1 2023~2033年の地域別市場規模(US$ Million)
4.5.2 地域別市場シェア、2023年~2033年 (%)

5 幹細胞技術と応用市場分析:細胞源別
5.1 主要な調査結果
5.2 細胞源セグメント 市場魅力度指数
5.3 幹細胞技術と応用の細胞源別市場規模の推定と予測
5.4 脂肪組織由来MSC
5.4.1 2023~2033年の地域別市場規模(US$ Million)
5.4.2 地域別市場シェア、2023年・2033年(%)
5.5 骨髄由来MSC
5.5.1 2023~2033年の地域別市場規模(US$ Million)
5.5.2 地域別市場シェア、2023年・2033年(%)
5.6 胎盤/臍帯由来MSC
5.6.1 2023~2033年の地域別市場規模(US$ Million)
5.6.2 地域別市場シェア、2023年・2033年(%)

6 幹細胞技術と応用市場分析:製品別
6.1 主要な調査結果
6.2 製品セグメント 市場魅力度指数
6.3 幹細胞技術と応用の製品別市場規模の推定と予測
6.4 成人幹細胞
6.4.1 2023~2033年の地域別市場規模(US$ Million)
6.4.2 地域別市場シェア、2023年・2033年(%)
6.5 ヒト胚性幹細胞
6.5.1 2023~2033年の地域別市場規模(US$ Million)
6.5.2 地域別市場シェア、2023年及び2033年(%)
6.6 人工多能性幹細胞
6.6.1 2023~2033年の地域別市場規模(US$ Million)
6.6.2 地域別市場シェア、2023年及び2033年(%)
6.7 極小胚様幹細胞
6.7.1 2023~2033年の地域別市場規模(US$ Million)
6.7.2 地域別市場シェア、2023年~2033年 (%)

7 幹細胞技術と応用市場分析:技術別
7.1 主要な調査結果
7.2 技術セグメント 市場魅力度指数
7.3 幹細胞技術と応用の技術別市場規模の推定と予測
7.4 細胞取得
7.4.1 2023~2033年の地域別市場規模(US$ Million)
7.4.2 地域別市場シェア、2023年・2033年(%)
7.5 細胞生産
7.5.1 2023~2033年の地域別市場規模(US$ Million)
7.5.2 地域別市場シェア、2023年・2033年(%)
7.6 凍結保存
7.6.1 2023~2033年の地域別市場規模(US$ Million)
7.6.2 地域別市場シェア、2023年・2033年(%)
7.7 拡張・サブカルチャー
7.7.1 2023~2033年の地域別市場規模(US$ Million)
7.7.2 地域別市場シェア、2023年・2033年(%)
7.8 その他の技術
7.8.1 2023~2033年の地域別市場規模(US$ Million)
7.8.2 地域別市場シェア、2023年~2033年(%)

8 幹細胞技術と応用市場分析応用
8.1 主要な調査結果
8.2 応用セグメント 市場魅力度指数
8.3 幹細胞技術と応用の用途別市場規模の推定と予測
8.4 癌
8.4.1 2023-2033年の地域別市場規模(US$ Million)
8.4.2 地域別市場シェア、2023年・2033年(%)
8.5 循環器疾患
8.5.1 2023〜2033年の地域別市場規模(US$ Million)
8.5.2 地域別市場シェア、2023年・2033年(%)
8.6 神経疾患
8.6.1 2023〜2033年の地域別市場規模(US$ Million)
8.6.2 地域別市場シェア、2023年・2033年(%)
8.7 炎症性疾患および自己免疫疾患
8.7.1 2023〜2033年の地域別市場規模(US$ Million)
8.7.2 地域別市場シェア、2023年・2033年(%)
8.8 筋骨格系疾患
8.8.1 2023〜2033年の地域別市場規模(US$ Million)
8.8.2 地域別市場シェア、2023年・2033年(%)
8.9 その他の用途
8.9.1 2023〜2033年の地域別市場規模(US$ Million)
8.9.2 地域別市場シェア、2023年~2033年 (%)

9 幹細胞技術と応用の市場分析:エンドユーズ別
9.1 主要な調査結果
9.2 エンドユーズセグメント 市場魅力度指数
9.3 幹細胞技術と応用のエンドユース別市場規模の推定と予測
9.4 製薬・バイオテクノロジー企業
9.4.1 2023年~2033年の地域別市場規模(US$ Million)
9.4.2 地域別市場シェア、2023年・2033年(%)
9.5 病院・細胞バンク
9.5.1 2023~2033年の地域別市場規模(US$ Million)
9.5.2 地域別市場シェア、2023年・2033年(%)
9.6 学術・研究機関
9.6.1 2023~2033年の地域別市場規模(US$ Million)
9.6.2 地域別市場シェア、2023年~2033年(%)

10 幹細胞技術と応用市場分析:地域別
10.1 主要な調査結果
10.2 地域別市場規模の推定と予測

11 北米の幹細胞技術と応用市場分析
11.1 主要な調査結果
11.2 北米の幹細胞技術と応用市場魅力度指数
11.3 北米の幹細胞技術と応用国別市場、2023年、2028年、2033年、(US$ Million)
11.4 北米の幹細胞技術と応用市場規模推定と予測:国別
11.5 北米の幹細胞技術と応用市場規模推定と予測:タイプ別
11.6 北米の幹細胞技術と応用市場規模推定と予測:細胞源別
11.7 北米の幹細胞技術と応用市場規模推定と予測:製品別
11.8 北米の幹細胞技術と応用市場規模推定と予測:技術別
11.9 北米の幹細胞技術と応用市場規模推定と予測:用途別
11.10 北米の幹細胞技術と応用市場規模推定と予測:エンドユーズ別
11.11 米国の幹細胞技術と応用市場分析
11.12 カナダの幹細胞技術と応用市場分析

12 欧州の幹細胞技術と応用市場分析
12.1 主要な調査結果
12.2 欧州の幹細胞技術と応用市場魅力度指数
12.3 欧州の幹細胞技術と応用国別市場、2023年、2028年、2033年(US$ Million)
12.4 欧州の幹細胞技術と応用市場規模推定と予測:国別
12.5 欧州の幹細胞技術と応用市場規模推定と予測:タイプ別
12.6 欧州の幹細胞技術と応用市場規模推定と予測:細胞源別
12.7 欧州の幹細胞技術と応用市場規模推定と予測:製品別
12.8 欧州の幹細胞技術と応用市場規模推定と予測:技術別
12.9 欧州の幹細胞技術と応用市場規模推定と予測:用途別
12.10 欧州の幹細胞技術と応用市場規模推定と予測:エンドユーズ別
12.11 ドイツの幹細胞技術と応用市場分析
12.12 イギリスの幹細胞技術と応用市場分析
12.13 フランスの幹細胞技術と応用市場分析
12.14 イタリアの幹細胞技術と応用市場分析
12.15 スペインの幹細胞技術と応用市場分析
12.16 その他の欧州の幹細胞技術と応用市場分析

13 アジア太平洋地域の幹細胞技術と応用市場分析
13.1 主要な調査結果
13.2 アジア太平洋地域の幹細胞技術と応用市場魅力度指数
13.3 アジア太平洋地域の幹細胞技術と応用国別市場、2023年、2028年、2033年(US$ Million)
13.4 アジア太平洋地域の幹細胞技術と応用市場規模推定と予測:国別
13.5 アジア太平洋地域の幹細胞技術と応用市場規模推定と予測:タイプ別
13.6 アジア太平洋地域の幹細胞技術と応用市場規模推定と予測:細胞源別
13.7 アジア太平洋地域の幹細胞技術と応用市場規模推定と予測:製品別
13.8 アジア太平洋地域の幹細胞技術と応用市場規模推定と予測:技術別
13.9 アジア太平洋地域の幹細胞技術と応用市場規模推定と予測:用途別
13.10 アジア太平洋地域の幹細胞技術と応用市場規模推定と予測:エンドユーズ別
13.11 中国の幹細胞技術と応用市場分析
13.12 日本の幹細胞技術と応用市場分析
13.13 インドの幹細胞技術と応用市場分析
13.14 オーストラリアの幹細胞技術と応用市場分析
13.15 韓国の幹細胞技術と応用市場分析
13.16 その他のアジア太平洋地域の幹細胞技術と応用市場分析

14 ラテンアメリカの幹細胞技術と応用市場分析
14.1 主要な調査結果
14.2 ラテンアメリカの幹細胞技術と応用市場魅力度指数
14.3 ラテンアメリカの幹細胞技術と応用国別市場、2023年、2028年、2033年(US$ Million)
14.4 ラテンアメリカの幹細胞技術と応用市場規模推定と予測:国別
14.5 ラテンアメリカの幹細胞技術と応用市場規模推定と予測:タイプ別
14.6 ラテンアメリカの幹細胞技術と応用市場規模推定と予測:細胞源別
14.7 ラテンアメリカの幹細胞技術と応用市場規模推定と予測:製品別
14.8 ラテンアメリカの幹細胞技術と応用市場規模推定と予測:技術別
14.9 ラテンアメリカの幹細胞技術と応用市場規模推定と予測:用途別
14.10 ラテンアメリカの幹細胞技術と応用市場規模推定と予測:エンドユーズ別
14.11 ブラジルの幹細胞技術と応用市場分析
14.12 メキシコ幹細胞技術と応用市場分析
14.13 その他のラテンアメリカの幹細胞技術と応用市場分析

15 MEAの幹細胞技術と応用市場分析
15.1 主要な調査結果
15.2 MEAの幹細胞技術と応用市場魅力度指数
15.3 MEAの幹細胞技術と応用国別市場、2023年、2028年、2033年(US$ Million)
15.4 MEAの幹細胞技術と応用市場規模推定と予測:国別
15.5 MEAの幹細胞技術と応用市場規模推定と予測:タイプ別予測
15.6 MEAの幹細胞技術と応用市場規模推定と予測:細胞源別
15.7 MEAの幹細胞技術と応用市場規模推定と予測:製品別
15.8 MEAの幹細胞技術と応用市場規模推定と予測:技術別予測
15.9 MEAの幹細胞技術と応用市場規模推定と予測:用途別予測
15.10 MEAの幹細胞技術と応用市場規模推定と予測:エンドユーズ別
15.11 南アフリカの幹細胞技術と応用市場分析
15.12 GCCの幹細胞技術と応用市場分析
15.13 その他のMEAの幹細胞技術と応用市場分析

16 会社概要
16.1 競争環境、2022年
16.2 戦略的展望
16.3 Thermo Fisher Scientific Inc.
16.3.1 会社概要
16.3.2 会社概要
16.3.3 財務分析
16.3.3.1 純収入、2017-2022年
16.3.3.2 R&D、2017-2022年
16.3.3.3 地域市場シェア、2022年
16.3.4 製品ベンチマーク
16.3.5 戦略的展望
16.4 Becton, Dickinson and Company
16.4.1 会社概要
16.4.2 会社概要
16.4.3 財務分析
16.4.3.1 純収入、2017-2022年
16.4.3.2 R&D、2017-2022年
16.4.3.3 地域市場シェア、2022年
16.4.4 製品ベンチマーク
16.4.5 戦略的展望
16.5 STEMCELL Technologies Inc.
16.5.1 会社概要
16.5.2 会社概要
16.5.3 製品ベンチマーク
16.6 Merck KGaA
16.6.1 会社概要
16.6.2 会社概要
16.6.3 財務分析
16.6.3.1 純収入、2017-2022年
16.6.3.2 R&D、2017年〜2022年
16.6.3.3 地域市場シェア、2022年
16.6.4 製品ベンチマーク
16.7 Athersys, Inc.
16.7.1 会社概要
16.7.2 会社概要
16.7.3 財務分析
16.7.3.1 純収入、2017-2022年
16.7.3.2 売上高、2017-2022年
16.7.4 製品ベンチマーク
16.7.5 戦略的展望
16.8 Mesoblast Limited
16.8.1 会社概要
16.8.2 会社概要
16.8.3 製品ベンチマーク
16.9 Cynata Therapeutics Limited
16.9.1 会社概要
16.9.2 会社概要
16.9.3 財務分析
16.9.3.1 純収入、2017-2022年
16.9.4 製品ベンチマーク
16.10 Plus Therapeutics, Inc.
16.10.1 会社概要
16.10.2 会社概要
16.10.3 製品ベンチマーク
16.10.4 戦略的展望
16.11 Biorestorative Therapies, Inc.
16.11.1 会社概要
16.11.2 会社概要
16.11.3 製品ベンチマーク
16.12 CELLAÏON SA
16.12.1 会社概要
16.12.2 会社概要
16.12.3 製品ベンチマーク
16.13 Sangamo Therapeutics, Inc.
16.13.1 会社概要
16.13.2 会社概要
16.13.3 財務分析
16.13.3.1 純収入、2017-2022年
16.13.3.2 売上高、2017-2022年
16.13.4 製品ベンチマーク
16.14 Vericel Corporation
16.14.1 会社概要
16.14.2 会社概要
16.14.3 財務分析
16.14.3.1 純収入、2017-2022年
16.14.3.2 R&D、2017-2022年
16.14.4 製品ベンチマーク

17 結論と提言
17.1 Visiongainからの結びの言葉
17.2 市場プレイヤーへの提言

 

ページTOPに戻る



図表リスト

表の一覧
Table 1 Stem Cell Technologies and Applications Market Snapshot, 2023 & 2033 (US$ Million, AGR %)
Table 2 Stem Cell Technologies and Applications Market Forecast by Region, 2023-2033 (US$ Million, CAGR%): “V” Shaped Recovery
Table 3 Stem Cell Technologies and Applications Market Forecast by Region, 2023-2033 (US$ Million, CAGR%): “U” Shaped Recovery
Table 4 Stem Cell Technologies and Applications Market Forecast by Region, 2023-2033 (US$ Million, CAGR%): “W” Shaped Recovery
Table 5 Stem Cell Technologies and Applications Market Forecast by Region, 2023-2033 (US$ Million, CAGR%): “L” Shaped Recovery
Table 6 Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, CAGR%)
Table 7 Allogeneic Stem Cell Therapy Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 8 Autologous Stem Cell Therapy Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 9 Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, CAGR%)
Table 10 Adipose Tissue-derived MSCs Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 11 Bone Marrow-derived MSCs Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 12 Placental/umbilical cord-derived MSCs Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 13 Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, CAGR%)
Table 14 Adult Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 15 Human Embryonic Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 16 Induced Pluripotent Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 17 Very Small Embryonic Like Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 18 Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, CAGR%)
Table 19 Cell Acquisition Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 20 Cell Production Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 21 Cryopreservation Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 22 Expansion & Sub-culture Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 23 Other Technology Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 24 Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, CAGR%)
Table 25 Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 26 Cardiovascular Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 Neurological Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 28 Inflammatory & Autoimmune Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 29 Musculoskeletal Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 30 Other Application Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 31 Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, CAGR%)
Table 32 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 33 Hospitals & Cell Banks Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 34 Academic & Research Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 35 Stem Cell Technologies and Applications Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Table 36 North America Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Table 37 North America Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Table 38 North America Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Table 39 North America Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Table 40 North America Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Table 41 North America Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Table 42 North America Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Table 43 U.S. Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 44 Canada Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 45 Europe Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Table 46 Europe Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Table 47 Europe Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Table 48 Europe Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Table 49 Europe Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Table 50 Europe Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Table 51 Europe Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Table 52 Germany Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 53 UK Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 54 France Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 55 Italy Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 56 Spain Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 57 Rest of Europe Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 58 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Table 59 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Table 60 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Table 61 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Table 62 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Table 63 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Table 64 Asia Pacific Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Table 65 China Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 66 Japan Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 67 India Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 68 Australia Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 69 South Korea Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 70 Rest of Asia Pacific Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 71 Latin America Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Table 72 Latin America Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Table 73 Latin America Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Table 74 Latin America Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Table 75 Latin America Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Table 76 Latin America Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Table 77 Latin America Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Table 78 Brazil Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 79 Mexico Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 80 Rest of Latin America Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 81 MEA Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Table 82 MEA Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Table 83 MEA Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Table 84 MEA Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Table 85 MEA Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Table 86 MEA Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Table 87 MEA Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Table 88 South Africa Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 89 GCC Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 90 Rest of MEA Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 91 Strategic Outlook
Table 92 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 94 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 95 Becton, Dickinson and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Becton, Dickinson and Company.: Product Benchmarking
Table 97 Becton, Dickinson and Company.: Strategic Outlook
Table 98 STEMCELL Technologies Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 STEMCELL Technologies Inc.: Product Benchmarking
Table 100 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Merck KGaA.: Product Benchmarking
Table 102 Athersys, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 Athersys, Inc.: Product Benchmarking
Table 104 Athersys, Inc.: Strategic Outlook
Table 105 Mesoblast Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 Mesoblast Limited: Product Benchmarking
Table 107 Cynata Therapeutics Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Cynata Therapeutics Limited: Product Benchmarking
Table 109 Plus Therapeutics, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Plus Therapeutics, Inc.: Product Benchmarking
Table 111 Plus Therapeutics, Inc.: Strategic Outlook
Table 112 Biorestorative Therapies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Biorestorative Therapies, Inc.: Product Benchmarking
Table 114 Cellaïon SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 CELLAÏON SA: Product Benchmarking
Table 116 Sangamo Therapeutics, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 SANGAMO THERAPEUTICS, INC.: Product Benchmarking
Table 118 Vericel Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 VERICEL CORPORATION: Product Benchmarking

図の一覧
Figure 1 Stem Cell Technologies and Applications Market Segmentation
Figure 2 Stem Cell Technologies and Applications Market by Product: Market Attractiveness Index
Figure 3 Stem Cell Technologies and Applications Market by Cell Source: Market Attractiveness Index
Figure 4 Stem Cell Technologies and Applications Market by Type: Market Attractiveness Index
Figure 5 Stem Cell Technologies and Applications Market by Technology: Market Attractiveness Index
Figure 6 Stem Cell Technologies and Applications Market by Application: Market Attractiveness Index
Figure 7 Stem Cell Technologies and Applications Market by End-use: Market Attractiveness Index
Figure 8 Stem Cell Technologies and Applications Market Attractiveness Index by Region
Figure 9 Stem Cell Technologies and Applications Market: Market Dynamics
Figure 10 Stem Cell Technologies and Applications Market by Region, 2023-2033 (US$ Million, AGR %): “V” Shaped Recovery
Figure 11 Stem Cell Technologies and Applications Market by Region, 2023-2033 (US$ Million, AGR %): “U” Shaped Recovery
Figure 12 Stem Cell Technologies and Applications Market by Region, 2023-2033 (US$ Million, AGR %): “W” Shaped Recovery
Figure 13 Stem Cell Technologies and Applications Market by Region, 2023-2033 (US$ Million, AGR %): “L” Shaped Recovery
Figure 14 PEST Analysis of Stem Cell Technologies and Applications Market
Figure 15 Stem Cell Technologies and Applications Market by Type: Market Attractiveness Index
Figure 16 Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 17 Stem Cell Technologies and Applications Market Share Forecast by Type, 2023, 2028, 2033 (%)
Figure 18 Allogeneic Stem Cell Therapy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 19 Allogeneic Stem Cell Therapy Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 20 Autologous Stem Cell Therapy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 21 Autologous Stem Cell Therapy Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 22 Stem Cell Technologies and Applications Market by Cell Source: Market Attractiveness Index
Figure 23 Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Figure 24 Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2023, 2028, 2033 (%)
Figure 25 Adipose Tissue-derived MSCs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 26 Adipose Tissue-derived MSCs Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Bone Marrow-derived MSCs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 28 Bone Marrow-derived MSCs Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Placental/umbilical cord-derived MSCs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 30 Placental/umbilical cord-derived MSCs Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 31 Stem Cell Technologies and Applications Market by Product: Market Attractiveness Index
Figure 32 Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Figure 33 Stem Cell Technologies and Applications Market Share Forecast by Product, 2023, 2028, 2033 (%)
Figure 34 Adult Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 35 Adult Stem Cells Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Human Embryonic Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 37 Human Embryonic Stem Cells Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Induced Pluripotent Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 39 Induced Pluripotent Stem Cells Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 40 Very Small Embryonic Like Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 41 Very Small Embryonic Like Stem Cells Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 42 Stem Cell Technologies and Applications Market by Technology: Market Attractiveness Index
Figure 43 Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 44 Stem Cell Technologies and Applications Market Share Forecast by Technology, 2023, 2028, 2033 (%)
Figure 45 Cell Acquisition Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 46 Cell Acquisition Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 Cell Production Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 48 Cell Production Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Cryopreservation Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 50 Cryopreservation Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 51 Expansion & Sub-culture Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 52 Expansion & Sub-culture Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 53 Other Technology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 54 Other Technology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 55 Stem Cell Technologies and Applications Market by Application: Market Attractiveness Index
Figure 56 Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 57 Stem Cell Technologies and Applications Market Share Forecast by Application, 2023, 2028, 2033 (%)
Figure 58 Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 59 Cancer Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 60 Cardiovascular Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 61 Cardiovascular Diseases Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 62 Neurological Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 63 Neurological Disorders Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 64 Inflammatory & Autoimmune Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 65 Inflammatory & Autoimmune Diseases Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 66 Musculoskeletal Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 67 Musculoskeletal Disorders Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 68 Other Application Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 69 Other Application Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 70 Stem Cell Technologies and Applications Market by End-use: Market Attractiveness Index
Figure 71 Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Figure 72 Stem Cell Technologies and Applications Market Share Forecast by End-use, 2023, 2028, 2033 (%)
Figure 73 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 74 Pharmaceutical & Biotechnology Companies Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 75 Hospitals & Cell Banks Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 76 Hospitals & Cell Banks Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 77 Academic & Research Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 78 Academic & Research Institutes Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 79 Stem Cell Technologies and Applications Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
Figure 80 Stem Cell Technologies and Applications Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 81 Stem Cell Technologies and Applications Market by Region, 2023-2033 (US$ Million, AGR %)
Figure 82 North America Stem Cell Technologies and Applications Market Attractiveness Index
Figure 83 North America Stem Cell Technologies and Applications Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 84 North America Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 85 North America Stem Cell Technologies and Applications Market Share Forecast by Country, 2023 & 2033 (%)
Figure 86 North America Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 87 North America Stem Cell Technologies and Applications Market Share Forecast by Type, 2023 & 2033 (%)
Figure 88 North America Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Figure 89 North America Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2023 & 2033 (%)
Figure 90 North America Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Figure 91 North America Stem Cell Technologies and Applications Market Share Forecast by Product, 2023 & 2033 (%)
Figure 92 North America Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 93 North America Stem Cell Technologies and Applications Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 94 North America Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 95 North America Stem Cell Technologies and Applications Market Share Forecast by Application, 2023 & 2033 (%)
Figure 96 North America Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Figure 97 North America Stem Cell Technologies and Applications Market Share Forecast by End-use, 2023 & 2033 (%)
Figure 98 U.S. Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 99 Canada Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 100 Europe Stem Cell Technologies and Applications Market Attractiveness Index
Figure 101 Europe Stem Cell Technologies and Applications Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 102 Europe Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 103 Europe Stem Cell Technologies and Applications Market Share Forecast by Country, 2023 & 2033 (%)
Figure 104 Europe Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 105 Europe Stem Cell Technologies and Applications Market Share Forecast by Type, 2023 & 2033 (%)
Figure 106 Europe Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Figure 107 Europe Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2023 & 2033 (%)
Figure 108 Europe Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Figure 109 Europe Stem Cell Technologies and Applications Market Share Forecast by Product, 2023 & 2033 (%)
Figure 110 Europe Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 111 Europe Stem Cell Technologies and Applications Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 112 Europe Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 113 Europe Stem Cell Technologies and Applications Market Share Forecast by Application, 2023 & 2033 (%)
Figure 114 Europe Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Figure 115 Europe Stem Cell Technologies and Applications Market Share Forecast by End-use, 2023 & 2033 (%)
Figure 116 Germany Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 117 UK Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 118 France Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 119 Italy Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 120 Spain Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 121 Rest of Europe Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 122 Asia Pacific Stem Cell Technologies and Applications Market Attractiveness Index
Figure 123 Asia Pacific Stem Cell Technologies and Applications Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 124 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 125 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by Country, 2023 & 2033 (%)
Figure 126 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 127 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by Type, 2023 & 2033 (%)
Figure 128 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Figure 129 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2023 & 2033 (%)
Figure 130 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Figure 131 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by Product, 2023 & 2033 (%)
Figure 132 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 133 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 134 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 135 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by Application, 2023 & 2033 (%)
Figure 136 Asia Pacific Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Figure 137 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by End-use, 2023 & 2033 (%)
Figure 138 China Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 139 Japan Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 140 India Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 141 Australia Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 142 South Korea Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 143 Rest of Asia Pacific Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 144 Latin America Stem Cell Technologies and Applications Market Attractiveness Index
Figure 145 Latin America Stem Cell Technologies and Applications Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 146 Latin America Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 147 Latin America Stem Cell Technologies and Applications Market Share Forecast by Country, 2023 & 2033 (%)
Figure 148 Latin America Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 149 Latin America Stem Cell Technologies and Applications Market Share Forecast by Type, 2023 & 2033 (%)
Figure 150 Latin America Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Figure 151 Latin America Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2023 & 2033 (%)
Figure 152 Latin America Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Figure 153 Latin America Stem Cell Technologies and Applications Market Share Forecast by Product, 2023 & 2033 (%)
Figure 154 Latin America Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 155 Latin America Stem Cell Technologies and Applications Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 156 Latin America Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 157 Latin America Stem Cell Technologies and Applications Market Share Forecast by Application, 2023 & 2033 (%)
Figure 158 Latin America Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Figure 159 Latin America Stem Cell Technologies and Applications Market Share Forecast by End-use, 2023 & 2033 (%)
Figure 160 Brazil Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 161 Mexico Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 162 Rest of Latin America Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 163 MEA Stem Cell Technologies and Applications Market Attractiveness Index
Figure 164 MEA Stem Cell Technologies and Applications Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 165 MEA Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 166 MEA Stem Cell Technologies and Applications Market Share Forecast by Country, 2023 & 2033 (%)
Figure 167 MEA Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 168 MEA Stem Cell Technologies and Applications Market Share Forecast by Type, 2023 & 2033 (%)
Figure 169 MEA Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Figure 170 MEA Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2023 & 2033 (%)
Figure 171 MEA Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Figure 172 MEA Stem Cell Technologies and Applications Market Share Forecast by Product, 2023 & 2033 (%)
Figure 173 MEA Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 174 MEA Stem Cell Technologies and Applications Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 175 MEA Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 176 MEA Stem Cell Technologies and Applications Market Share Forecast by Application, 2023 & 2033 (%)
Figure 177 MEA Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Figure 178 MEA Stem Cell Technologies and Applications Market Share Forecast by End-use, 2023 & 2033 (%)
Figure 179 South Africa Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 180 GCC Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 181 Rest of MEA Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 182 Stem Cell Technologies and Applications Market: Company Share/Ranking, 2022
Figure 183 Thermo Fisher Scientific Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 184 Thermo Fisher Scientific Inc.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 185 Thermo Fisher Scientific Inc.: Regional Market Shares, 2022
Figure 186 Becton, Dickinson and Company: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 187 Becton, Dickinson and Company.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 188 Becton, Dickinson and Company.: Regional Market Shares, 2022
Figure 189 Merck KGaA: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 190 Merck KGaA.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 191 Merck KGaA.: Regional Market Shares, 2022
Figure 192 Athersys, Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 193 Athersys, Inc.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 194 Cynata Therapeutics Limited: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 195 Sangamo Therapeutics: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 196 Sangamo Therapeutics: R&D, 2017-2022 (US$ Million, AGR%)
Figure 197 Vericel Corporation: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 198 Vericel Corporation: R&D, 2017-2022 (US$ Million, AGR%)

 

ページTOPに戻る


 

Summary

Report Details

The Stem Cell Technologies and Applications Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to understand the industry and its underlying dynamics better. It will be useful for companies that want to expand into different industries or their existing operations in a new region.

Growing Government Support Driving Market Growth
Growing government support for stem cell research and development is fuelling the growth of stem cell companies. In 2022, we saw a number of significant developments in this area. Global governments are making significant investments in stem cell research. For instance, the US National Institutes of Health (NIH) funded stem cell research with $3.7 billion in 2022. New programmes are being introduced by governments to assist stem cell companies. In 2022, for instance, the UK government established a new fund worth £30 million ($37 million) to assist stem cell firms in introducing novel therapies to the market.

Furthermore, there is a developing trend in the industry. This indicates that investors’ interest in this industry is rising. Verve Therapeutics, a stem cell firm, raised $100 million at its first public offering (IPO) in 2022.

The following are a few specific advances in stem cell companies that happened in 2022:
• Clinical studies for stem cell therapies: In 2022, several stem cell therapies were introduced into clinical trials. For instance, a Phase 3 clinical trial for the stem cell therapy for sickle cell disease was started by Bluebird Bio.
• Regulatory clearances for stem cell companies: In 2022, a number of stem cell companies were granted regulatory approvals. For instance, Kite Pharma, a stem cell business, was approved by the FDA to use stem cells to treat non-Hodgkin lymphoma.

These are but a handful of the numerous advancements that the stem cell sector saw in 2022. This rise is mostly due to the growing support from the government, which is expected to encourage the creation of new stem cell medicines as well as the expansion of stem cell companies in the years to come.

High Cost of Stem Cell Therapies to Hamper Industry Growth
A variety of illnesses and disorders may be treated or made better with the help of stem cell therapy, a cutting-edge medical innovation. The high expense of stem cell therapy is one of the main obstacles, though. Depending on the type of stem cells utilised, the ailment being treated, and the location of the treatment centre, the average cost of stem cell therapy today ranges from $5,000 to $50,000.

The high price of stem cell therapy is caused by a variety of variables. The price of creating and developing stem cell therapies is one of the factors. The production of stem cell therapies is difficult and demands a high level of knowledge and technology. The expense of stem cell therapies is further increased by the fact that they are frequently customised for each patient.

The absence of insurance coverage is another reason that raises the price of stem cell therapy. Due to the fact that stem cell therapy is currently regarded as an experimental procedure, the majority of insurance companies do not cover it. This implies that patients frequently bear the financial burden of covering the entire expense of treatment.

What Questions Should You Ask Before Buying a Market Research Report?
• How is the stem cell technologies and applications market evolving?
• What is driving and restraining stem cell technologies and applications market?
• How will each stem cell technologies and applications submarket segment grow over the forecast period, and how much revenue will these submarkets account for in 2033?
• How will the market shares for each stem cell technologies and applications submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading stem cell technologies and applications markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033, and which geographical region will lead the market in 2033?
• Who are the leading players, and what are their prospects over the forecast period?
• What are the stem cell technologies and applications projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of stem cell technologies and applications projects taking place now and over the next 10 years?
• Is there a greater need for product commercialization to further scale stem cell technologies and applications market?
• Where is the stem cell technologies and applications market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the stem cell technologies and applications market today, and over the next 10 years:
• Our 337-page report provides 119 tables and 198 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the stem cell technologies and applications market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising stem cell technologies and applications prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Type Outlook
• Allogeneic Stem Cell Therapy
• Autologous Stem Cell Therapy

Cell Source
• Adipose Tissue-derived MSCs
• Bone Marrow-derived MSCs
• Placental/Umbilical Cord-derived MSCs

Product
• Adult Stem Cells
• Human Embryonic Stem Cells
• Induced Pluripotent Stem Cells
• Very Small Embryonic Like Stem Cells

Technology
• Cell Acquisition
• Cell Production
• Cryopreservation
• Expansion & Sub-culture
• Other Technology

Application
• Cancer
• Cardiovascular Diseases
• Neurological Disorders
• Inflammatory & Autoimmune Diseases
• Musculoskeletal Disorders
• Other Applications

End-Use
• Pharmaceutical & Biotechnology Companies
• Hospitals & Cell Banks
• Academic & Research Institutes

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and the U.S., China, U.K., India, and Brazil leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Stem Cell Technologies and Applications Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading Companies and the Potential for market growth
• Athersys, Inc.
• Becton, Dickinson and Company
• Biorestorative Therapies, Inc.
• CELLAÏON SA
• Cynata Therapeutics Limited
• Merck KGaA
• Mesoblast Limited
• Plus Therapeutics, Inc.
• Sangamo Therapeutics, Inc.
• STEMCELL Technologies Inc.
• Thermo Fisher Scientific Inc.
• Vericel Corporation

Overall world revenue for Stem Cell Technologies and Applications Market, 2023 to 2033 in terms of value the market will surpass US$10,000.0 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Stem Cell Technologies and Applications Market, 2023 to 2033 report help you?
In summary, our 330+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Stem Cell Technologies and Applications Market, 2023 to 2033 Market, with forecasts for type, cell source, product, technology, application, and end use each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 20 key national markets – See forecasts for the Stem Cell Technologies and Applications Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for Thermo Fisher Scientific Inc., Becton, Dickinson and Company, STEMCELL Technologies Inc., Merck KGaA of the major companies involved in the Stem Cell Technologies and Applications Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Stem Cell Technologies and Applications Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.



ページTOPに戻る


Table of Contents

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Stem Cell Technologies and Applications Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Rising Awareness About Stem Cell Therapies
3.2.1.2 Government Support for Stem Cell Research
3.2.1.3 Increasing Number of Clinical Trials
3.2.2 Market Restraining Factors
3.2.2.1 High Cost of Stem Cell Therapies
3.2.2.2 Lack of Regulatory Clarity
3.2.3 Market Opportunities
3.2.3.1 Increasing Investment in Stem Cell Research and Development
3.3 COVID-19 Impact Analysis
3.4 Porter Analysis
3.5 PEST Analysis

4 Stem Cell Technologies and Applications Market Analysis by Type
4.1 Key Findings
4.2 Type Segment: Market Attractiveness Index
4.3 Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
4.4 Allogeneic Stem Cell Therapy
4.4.1 Market Size by Region, 2023-2033 (US$ Million)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Autologous Stem Cell Therapy
4.5.1 Market Size by Region, 2023-2033 (US$ Million)
4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Stem Cell Technologies and Applications Market Analysis by Cell Source
5.1 Key Findings
5.2 Cell Source Segment: Market Attractiveness Index
5.3 Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
5.4 Adipose tissue-derived MSCs
5.4.1 Market Size by Region, 2023-2033 (US$ Million)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Bone marrow-derived MSCs
5.5.1 Market Size by Region, 2023-2033 (US$ Million)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Placental/umbilical cord-derived MSCs
5.6.1 Market Size by Region, 2023-2033 (US$ Million)
5.6.2 Market Share by Region, 2023 & 2033 (%)

6 Stem Cell Technologies and Applications Market Analysis by Product
6.1 Key Findings
6.2 Product Segment: Market Attractiveness Index
6.3 Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
6.4 Adult Stem Cells
6.4.1 Market Size by Region, 2023-2033 (US$ Million)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Human Embryonic Stem Cells
6.5.1 Market Size by Region, 2023-2033 (US$ Million)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Induced Pluripotent Stem Cells
6.6.1 Market Size by Region, 2023-2033 (US$ Million)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Very Small Embryonic Like Stem Cells
6.7.1 Market Size by Region, 2023-2033 (US$ Million)
6.7.2 Market Share by Region, 2023 & 2033 (%)

7 Stem Cell Technologies and Applications Market Analysis by Technology
7.1 Key Findings
7.2 Technology Segment: Market Attractiveness Index
7.3 Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
7.4 Cell Acquisition
7.4.1 Market Size by Region, 2023-2033 (US$ Million)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Cell Production
7.5.1 Market Size by Region, 2023-2033 (US$ Million)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 Cryopreservation
7.6.1 Market Size by Region, 2023-2033 (US$ Million)
7.6.2 Market Share by Region, 2023 & 2033 (%)
7.7 Expansion & Sub-Culture
7.7.1 Market Size by Region, 2023-2033 (US$ Million)
7.7.2 Market Share by Region, 2023 & 2033 (%)
7.8 Other Technology
7.8.1 Market Size by Region, 2023-2033 (US$ Million)
7.8.2 Market Share by Region, 2023 & 2033 (%)

8 Stem Cell Technologies and Applications Market Analysis by Application
8.1 Key Findings
8.2 Application Segment: Market Attractiveness Index
8.3 Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
8.4 Cancer
8.4.1 Market Size by Region, 2023-2033 (US$ Million)
8.4.2 Market Share by Region, 2023 & 2033 (%)
8.5 Cardiovascular Diseases
8.5.1 Market Size by Region, 2023-2033 (US$ Million)
8.5.2 Market Share by Region, 2023 & 2033 (%)
8.6 Neurological Disorders
8.6.1 Market Size by Region, 2023-2033 (US$ Million)
8.6.2 Market Share by Region, 2023 & 2033 (%)
8.7 Inflammatory & Autoimmune Diseases
8.7.1 Market Size by Region, 2023-2033 (US$ Million)
8.7.2 Market Share by Region, 2023 & 2033 (%)
8.8 Musculoskeletal Disorders
8.8.1 Market Size by Region, 2023-2033 (US$ Million)
8.8.2 Market Share by Region, 2023 & 2033 (%)
8.9 Other Application
8.9.1 Market Size by Region, 2023-2033 (US$ Million)
8.9.2 Market Share by Region, 2023 & 2033 (%)

9 Stem Cell Technologies and Applications Market Analysis by End-use
9.1 Key Findings
9.2 End-use Segment: Market Attractiveness Index
9.3 Stem Cell Technologies and Applications Market Size Estimation and Forecast by End-use
9.4 Pharmaceutical & Biotechnology Companies
9.4.1 Market Size by Region, 2023-2033 (US$ Million)
9.4.2 Market Share by Region, 2023 & 2033 (%)
9.5 Hospitals & Cell Banks
9.5.1 Market Size by Region, 2023-2033 (US$ Million)
9.5.2 Market Share by Region, 2023 & 2033 (%)
9.6 Academic & Research Institutes
9.6.1 Market Size by Region, 2023-2033 (US$ Million)
9.6.2 Market Share by Region, 2023 & 2033 (%)

10 Stem Cell Technologies and Applications Market Analysis by Region
10.1 Key Findings
10.2 Regional Market Size Estimation and Forecast

11 North America Stem Cell Technologies and Applications Market Analysis
11.1 Key Findings
11.2 North America Stem Cell Technologies and Applications Market Attractiveness Index
11.3 North America Stem Cell Technologies and Applications Market by Country, 2023, 2028 & 2033 (US$ Million)
11.4 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Country
11.5 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
11.6 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
11.7 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
11.8 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
11.9 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
11.10 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by End-use
11.11 U.S. Stem Cell Technologies and Applications Market Analysis
11.12 Canada Stem Cell Technologies and Applications Market Analysis

12 Europe Stem Cell Technologies and Applications Market Analysis
12.1 Key Findings
12.2 Europe Stem Cell Technologies and Applications Market Attractiveness Index
12.3 Europe Stem Cell Technologies and Applications Market by Country, 2023, 2028 & 2033 (US$ Million)
12.4 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Country
12.5 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
12.6 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
12.7 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
12.8 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
12.9 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
12.10 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by End-use
12.11 Germany Stem Cell Technologies and Applications Market Analysis
12.12 UK Stem Cell Technologies and Applications Market Analysis
12.13 France Stem Cell Technologies and Applications Market Analysis
12.14 Italy Stem Cell Technologies and Applications Market Analysis
12.15 Spain Stem Cell Technologies and Applications Market Analysis
12.16 Rest of Europe Stem Cell Technologies and Applications Market Analysis

13 Asia-Pacific Stem Cell Technologies and Applications Market Analysis
13.1 Key Findings
13.2 Asia-Pacific Stem Cell Technologies and Applications Market Attractiveness Index
13.3 Asia-Pacific Stem Cell Technologies and Applications Market by Country, 2023, 2028 & 2033 (US$ Million)
13.4 Asia-Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Country
13.5 Asia Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
13.6 Asia Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
13.7 Asia Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
13.8 Asia Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
13.9 Asia Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
13.10 Asia Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by End-use
13.11 China Stem Cell Technologies and Applications Market Analysis
13.12 Japan Stem Cell Technologies and Applications Market Analysis
13.13 India Stem Cell Technologies and Applications Market Analysis
13.14 Australia Stem Cell Technologies and Applications Market Analysis
13.15 South Korea Stem Cell Technologies and Applications Market Analysis
13.16 Rest of Asia-Pacific Stem Cell Technologies and Applications Market Analysis

14 Latin America Stem Cell Technologies and Applications Market Analysis
14.1 Key Findings
14.2 Latin America Stem Cell Technologies and Applications Market Attractiveness Index
14.3 Latin America Stem Cell Technologies and Applications Market by Country, 2023, 2028 & 2033 (US$ Million)
14.4 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Country
14.5 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
14.6 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
14.7 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
14.8 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
14.9 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
14.10 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by End-use
14.11 Brazil Stem Cell Technologies and Applications Market Analysis
14.12 Mexico Stem Cell Technologies and Applications Market Analysis
14.13 Rest of Latin America Stem Cell Technologies and Applications Market Analysis

15 MEA Stem Cell Technologies and Applications Market Analysis
15.1 Key Findings
15.2 MEA Stem Cell Technologies and Applications Market Attractiveness Index
15.3 MEA Stem Cell Technologies and Applications Market by Country, 2023, 2028 & 2033 (US$ Million)
15.4 MEA Stem Cell Technologies and Applications Market Size Estimation and Forecast by Country
15.5 MEA Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
15.6 MEA Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
15.7 MEA Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
15.8 MEA Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
15.9 MEA Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
15.10 MEA Stem Cell Technologies and Applications Market Size Estimation and Forecast by End-use
15.11 South Africa Stem Cell Technologies and Applications Market Analysis
15.12 GCC Stem Cell Technologies and Applications Market Analysis
15.13 Rest of MEA Stem Cell Technologies and Applications Market Analysis

16 Company Profiles
16.1 Competitive Landscape, 2022
16.2 Strategic Outlook
16.3 Thermo Fisher Scientific Inc.
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Financial Analysis
16.3.3.1 Net Revenue, 2017-2022
16.3.3.2 R&D, 2017-2022
16.3.3.3 Regional Market Shares, 2022
16.3.4 Product Benchmarking
16.3.5 Strategic Outlook
16.4 Becton, Dickinson and Company
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Financial Analysis
16.4.3.1 Net Revenue, 2017-2022
16.4.3.2 R&D, 2017-2022
16.4.3.3 Regional Market Shares, 2022
16.4.4 Product Benchmarking
16.4.5 Strategic Outlook
16.5 STEMCELL Technologies Inc.
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Product Benchmarking
16.6 Merck KGaA
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Financial Analysis
16.6.3.1 Net Revenue, 2017-2022
16.6.3.2 R&D, 2017-2022
16.6.3.3 Regional Market Shares, 2022
16.6.4 Product Benchmarking
16.7 Athersys, Inc.
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Financial Analysis
16.7.3.1 Net Revenue, 2017-2022
16.7.3.2 R&D, 2017-2022
16.7.4 Product Benchmarking
16.7.5 Strategic Outlook
16.8 Mesoblast Limited
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Product Benchmarking
16.9 Cynata Therapeutics Limited
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Financial Analysis
16.9.3.1 Net Revenue, 2017-2022
16.9.4 Product Benchmarking
16.10 Plus Therapeutics, Inc.
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Product Benchmarking
16.10.4 Strategic Outlook
16.11 Biorestorative Therapies, Inc.
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Product Benchmarking
16.12 CELLAÏON SA
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Product Benchmarking
16.13 Sangamo Therapeutics, Inc.
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Financial Analysis
16.13.3.1 Net Revenue, 2017-2022
16.13.3.2 R&D, 2017-2022
16.13.4 Product Benchmarking
16.14 Vericel Corporation
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Financial Analysis
16.14.3.1 Net Revenue, 2017-2022
16.14.3.2 R&D, 2017-2022
16.14.4 Product Benchmarking

17 Conclusion and Recommendations
17.1 Concluding Remarks from Visiongain
17.2 Recommendations for Market Players

ページTOPに戻る



List of Tables/Graphs

List of Tables
Table 1 Stem Cell Technologies and Applications Market Snapshot, 2023 & 2033 (US$ Million, AGR %)
Table 2 Stem Cell Technologies and Applications Market Forecast by Region, 2023-2033 (US$ Million, CAGR%): “V” Shaped Recovery
Table 3 Stem Cell Technologies and Applications Market Forecast by Region, 2023-2033 (US$ Million, CAGR%): “U” Shaped Recovery
Table 4 Stem Cell Technologies and Applications Market Forecast by Region, 2023-2033 (US$ Million, CAGR%): “W” Shaped Recovery
Table 5 Stem Cell Technologies and Applications Market Forecast by Region, 2023-2033 (US$ Million, CAGR%): “L” Shaped Recovery
Table 6 Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, CAGR%)
Table 7 Allogeneic Stem Cell Therapy Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 8 Autologous Stem Cell Therapy Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 9 Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, CAGR%)
Table 10 Adipose Tissue-derived MSCs Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 11 Bone Marrow-derived MSCs Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 12 Placental/umbilical cord-derived MSCs Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 13 Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, CAGR%)
Table 14 Adult Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 15 Human Embryonic Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 16 Induced Pluripotent Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 17 Very Small Embryonic Like Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 18 Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, CAGR%)
Table 19 Cell Acquisition Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 20 Cell Production Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 21 Cryopreservation Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 22 Expansion & Sub-culture Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 23 Other Technology Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 24 Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, CAGR%)
Table 25 Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 26 Cardiovascular Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 Neurological Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 28 Inflammatory & Autoimmune Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 29 Musculoskeletal Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 30 Other Application Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 31 Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, CAGR%)
Table 32 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 33 Hospitals & Cell Banks Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 34 Academic & Research Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
Table 35 Stem Cell Technologies and Applications Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Table 36 North America Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Table 37 North America Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Table 38 North America Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Table 39 North America Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Table 40 North America Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Table 41 North America Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Table 42 North America Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Table 43 U.S. Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 44 Canada Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 45 Europe Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Table 46 Europe Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Table 47 Europe Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Table 48 Europe Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Table 49 Europe Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Table 50 Europe Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Table 51 Europe Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Table 52 Germany Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 53 UK Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 54 France Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 55 Italy Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 56 Spain Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 57 Rest of Europe Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 58 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Table 59 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Table 60 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Table 61 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Table 62 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Table 63 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Table 64 Asia Pacific Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Table 65 China Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 66 Japan Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 67 India Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 68 Australia Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 69 South Korea Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 70 Rest of Asia Pacific Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 71 Latin America Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Table 72 Latin America Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Table 73 Latin America Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Table 74 Latin America Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Table 75 Latin America Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Table 76 Latin America Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Table 77 Latin America Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Table 78 Brazil Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 79 Mexico Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 80 Rest of Latin America Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 81 MEA Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Table 82 MEA Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Table 83 MEA Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Table 84 MEA Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Table 85 MEA Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Table 86 MEA Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Table 87 MEA Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Table 88 South Africa Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 89 GCC Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 90 Rest of MEA Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Table 91 Strategic Outlook
Table 92 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 94 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 95 Becton, Dickinson and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Becton, Dickinson and Company.: Product Benchmarking
Table 97 Becton, Dickinson and Company.: Strategic Outlook
Table 98 STEMCELL Technologies Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 STEMCELL Technologies Inc.: Product Benchmarking
Table 100 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Merck KGaA.: Product Benchmarking
Table 102 Athersys, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 Athersys, Inc.: Product Benchmarking
Table 104 Athersys, Inc.: Strategic Outlook
Table 105 Mesoblast Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 Mesoblast Limited: Product Benchmarking
Table 107 Cynata Therapeutics Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Cynata Therapeutics Limited: Product Benchmarking
Table 109 Plus Therapeutics, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Plus Therapeutics, Inc.: Product Benchmarking
Table 111 Plus Therapeutics, Inc.: Strategic Outlook
Table 112 Biorestorative Therapies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Biorestorative Therapies, Inc.: Product Benchmarking
Table 114 Cellaïon SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 CELLAÏON SA: Product Benchmarking
Table 116 Sangamo Therapeutics, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 SANGAMO THERAPEUTICS, INC.: Product Benchmarking
Table 118 Vericel Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 VERICEL CORPORATION: Product Benchmarking

List of Figures
Figure 1 Stem Cell Technologies and Applications Market Segmentation
Figure 2 Stem Cell Technologies and Applications Market by Product: Market Attractiveness Index
Figure 3 Stem Cell Technologies and Applications Market by Cell Source: Market Attractiveness Index
Figure 4 Stem Cell Technologies and Applications Market by Type: Market Attractiveness Index
Figure 5 Stem Cell Technologies and Applications Market by Technology: Market Attractiveness Index
Figure 6 Stem Cell Technologies and Applications Market by Application: Market Attractiveness Index
Figure 7 Stem Cell Technologies and Applications Market by End-use: Market Attractiveness Index
Figure 8 Stem Cell Technologies and Applications Market Attractiveness Index by Region
Figure 9 Stem Cell Technologies and Applications Market: Market Dynamics
Figure 10 Stem Cell Technologies and Applications Market by Region, 2023-2033 (US$ Million, AGR %): “V” Shaped Recovery
Figure 11 Stem Cell Technologies and Applications Market by Region, 2023-2033 (US$ Million, AGR %): “U” Shaped Recovery
Figure 12 Stem Cell Technologies and Applications Market by Region, 2023-2033 (US$ Million, AGR %): “W” Shaped Recovery
Figure 13 Stem Cell Technologies and Applications Market by Region, 2023-2033 (US$ Million, AGR %): “L” Shaped Recovery
Figure 14 PEST Analysis of Stem Cell Technologies and Applications Market
Figure 15 Stem Cell Technologies and Applications Market by Type: Market Attractiveness Index
Figure 16 Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 17 Stem Cell Technologies and Applications Market Share Forecast by Type, 2023, 2028, 2033 (%)
Figure 18 Allogeneic Stem Cell Therapy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 19 Allogeneic Stem Cell Therapy Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 20 Autologous Stem Cell Therapy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 21 Autologous Stem Cell Therapy Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 22 Stem Cell Technologies and Applications Market by Cell Source: Market Attractiveness Index
Figure 23 Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Figure 24 Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2023, 2028, 2033 (%)
Figure 25 Adipose Tissue-derived MSCs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 26 Adipose Tissue-derived MSCs Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Bone Marrow-derived MSCs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 28 Bone Marrow-derived MSCs Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Placental/umbilical cord-derived MSCs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 30 Placental/umbilical cord-derived MSCs Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 31 Stem Cell Technologies and Applications Market by Product: Market Attractiveness Index
Figure 32 Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Figure 33 Stem Cell Technologies and Applications Market Share Forecast by Product, 2023, 2028, 2033 (%)
Figure 34 Adult Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 35 Adult Stem Cells Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Human Embryonic Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 37 Human Embryonic Stem Cells Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Induced Pluripotent Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 39 Induced Pluripotent Stem Cells Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 40 Very Small Embryonic Like Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 41 Very Small Embryonic Like Stem Cells Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 42 Stem Cell Technologies and Applications Market by Technology: Market Attractiveness Index
Figure 43 Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 44 Stem Cell Technologies and Applications Market Share Forecast by Technology, 2023, 2028, 2033 (%)
Figure 45 Cell Acquisition Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 46 Cell Acquisition Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 Cell Production Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 48 Cell Production Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Cryopreservation Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 50 Cryopreservation Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 51 Expansion & Sub-culture Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 52 Expansion & Sub-culture Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 53 Other Technology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 54 Other Technology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 55 Stem Cell Technologies and Applications Market by Application: Market Attractiveness Index
Figure 56 Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 57 Stem Cell Technologies and Applications Market Share Forecast by Application, 2023, 2028, 2033 (%)
Figure 58 Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 59 Cancer Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 60 Cardiovascular Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 61 Cardiovascular Diseases Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 62 Neurological Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 63 Neurological Disorders Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 64 Inflammatory & Autoimmune Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 65 Inflammatory & Autoimmune Diseases Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 66 Musculoskeletal Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 67 Musculoskeletal Disorders Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 68 Other Application Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 69 Other Application Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 70 Stem Cell Technologies and Applications Market by End-use: Market Attractiveness Index
Figure 71 Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Figure 72 Stem Cell Technologies and Applications Market Share Forecast by End-use, 2023, 2028, 2033 (%)
Figure 73 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 74 Pharmaceutical & Biotechnology Companies Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 75 Hospitals & Cell Banks Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 76 Hospitals & Cell Banks Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 77 Academic & Research Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 78 Academic & Research Institutes Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 79 Stem Cell Technologies and Applications Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
Figure 80 Stem Cell Technologies and Applications Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 81 Stem Cell Technologies and Applications Market by Region, 2023-2033 (US$ Million, AGR %)
Figure 82 North America Stem Cell Technologies and Applications Market Attractiveness Index
Figure 83 North America Stem Cell Technologies and Applications Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 84 North America Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 85 North America Stem Cell Technologies and Applications Market Share Forecast by Country, 2023 & 2033 (%)
Figure 86 North America Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 87 North America Stem Cell Technologies and Applications Market Share Forecast by Type, 2023 & 2033 (%)
Figure 88 North America Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Figure 89 North America Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2023 & 2033 (%)
Figure 90 North America Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Figure 91 North America Stem Cell Technologies and Applications Market Share Forecast by Product, 2023 & 2033 (%)
Figure 92 North America Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 93 North America Stem Cell Technologies and Applications Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 94 North America Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 95 North America Stem Cell Technologies and Applications Market Share Forecast by Application, 2023 & 2033 (%)
Figure 96 North America Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Figure 97 North America Stem Cell Technologies and Applications Market Share Forecast by End-use, 2023 & 2033 (%)
Figure 98 U.S. Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 99 Canada Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 100 Europe Stem Cell Technologies and Applications Market Attractiveness Index
Figure 101 Europe Stem Cell Technologies and Applications Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 102 Europe Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 103 Europe Stem Cell Technologies and Applications Market Share Forecast by Country, 2023 & 2033 (%)
Figure 104 Europe Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 105 Europe Stem Cell Technologies and Applications Market Share Forecast by Type, 2023 & 2033 (%)
Figure 106 Europe Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Figure 107 Europe Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2023 & 2033 (%)
Figure 108 Europe Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Figure 109 Europe Stem Cell Technologies and Applications Market Share Forecast by Product, 2023 & 2033 (%)
Figure 110 Europe Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 111 Europe Stem Cell Technologies and Applications Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 112 Europe Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 113 Europe Stem Cell Technologies and Applications Market Share Forecast by Application, 2023 & 2033 (%)
Figure 114 Europe Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Figure 115 Europe Stem Cell Technologies and Applications Market Share Forecast by End-use, 2023 & 2033 (%)
Figure 116 Germany Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 117 UK Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 118 France Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 119 Italy Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 120 Spain Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 121 Rest of Europe Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 122 Asia Pacific Stem Cell Technologies and Applications Market Attractiveness Index
Figure 123 Asia Pacific Stem Cell Technologies and Applications Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 124 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 125 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by Country, 2023 & 2033 (%)
Figure 126 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 127 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by Type, 2023 & 2033 (%)
Figure 128 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Figure 129 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2023 & 2033 (%)
Figure 130 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Figure 131 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by Product, 2023 & 2033 (%)
Figure 132 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 133 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 134 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 135 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by Application, 2023 & 2033 (%)
Figure 136 Asia Pacific Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Figure 137 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by End-use, 2023 & 2033 (%)
Figure 138 China Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 139 Japan Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 140 India Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 141 Australia Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 142 South Korea Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 143 Rest of Asia Pacific Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 144 Latin America Stem Cell Technologies and Applications Market Attractiveness Index
Figure 145 Latin America Stem Cell Technologies and Applications Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 146 Latin America Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 147 Latin America Stem Cell Technologies and Applications Market Share Forecast by Country, 2023 & 2033 (%)
Figure 148 Latin America Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 149 Latin America Stem Cell Technologies and Applications Market Share Forecast by Type, 2023 & 2033 (%)
Figure 150 Latin America Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Figure 151 Latin America Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2023 & 2033 (%)
Figure 152 Latin America Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Figure 153 Latin America Stem Cell Technologies and Applications Market Share Forecast by Product, 2023 & 2033 (%)
Figure 154 Latin America Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 155 Latin America Stem Cell Technologies and Applications Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 156 Latin America Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 157 Latin America Stem Cell Technologies and Applications Market Share Forecast by Application, 2023 & 2033 (%)
Figure 158 Latin America Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Figure 159 Latin America Stem Cell Technologies and Applications Market Share Forecast by End-use, 2023 & 2033 (%)
Figure 160 Brazil Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 161 Mexico Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 162 Rest of Latin America Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 163 MEA Stem Cell Technologies and Applications Market Attractiveness Index
Figure 164 MEA Stem Cell Technologies and Applications Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 165 MEA Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 166 MEA Stem Cell Technologies and Applications Market Share Forecast by Country, 2023 & 2033 (%)
Figure 167 MEA Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 168 MEA Stem Cell Technologies and Applications Market Share Forecast by Type, 2023 & 2033 (%)
Figure 169 MEA Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
Figure 170 MEA Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2023 & 2033 (%)
Figure 171 MEA Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Figure 172 MEA Stem Cell Technologies and Applications Market Share Forecast by Product, 2023 & 2033 (%)
Figure 173 MEA Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 174 MEA Stem Cell Technologies and Applications Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 175 MEA Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 176 MEA Stem Cell Technologies and Applications Market Share Forecast by Application, 2023 & 2033 (%)
Figure 177 MEA Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
Figure 178 MEA Stem Cell Technologies and Applications Market Share Forecast by End-use, 2023 & 2033 (%)
Figure 179 South Africa Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 180 GCC Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 181 Rest of MEA Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 182 Stem Cell Technologies and Applications Market: Company Share/Ranking, 2022
Figure 183 Thermo Fisher Scientific Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 184 Thermo Fisher Scientific Inc.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 185 Thermo Fisher Scientific Inc.: Regional Market Shares, 2022
Figure 186 Becton, Dickinson and Company: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 187 Becton, Dickinson and Company.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 188 Becton, Dickinson and Company.: Regional Market Shares, 2022
Figure 189 Merck KGaA: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 190 Merck KGaA.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 191 Merck KGaA.: Regional Market Shares, 2022
Figure 192 Athersys, Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 193 Athersys, Inc.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 194 Cynata Therapeutics Limited: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 195 Sangamo Therapeutics: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 196 Sangamo Therapeutics: R&D, 2017-2022 (US$ Million, AGR%)
Figure 197 Vericel Corporation: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 198 Vericel Corporation: R&D, 2017-2022 (US$ Million, AGR%)

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

本レポートと同じKEY WORD(banks)の最新刊レポート


よくあるご質問


Visiongain社はどのような調査会社ですか?


英国の調査会社ヴィジョンゲイン社(Visiongain)は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/03 10:27

162.61 円

175.23 円

209.12 円

ページTOPに戻る